News

Twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
BioSpace2h
Gilead Wins Historic Approval for Twice-Yearly HIV Drug
The FDA approved Gilead’s landmark long-acting HIV treatment lenacapavir Wednesday afternoon. The drug will be marketed under ...
Interesting Engineering3h
World’s first twice-a-year HIV prevention shot approved by FDA after 99.9% success
The FDA has approved Yeztugo, the world’s first twice-a-year HIV prevention shot, proven to stop 99.9% of infections in ...
FDA Approves a Twice-Yearly Shot to Prevent HIV
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Long-acting HIV prevention drug from Gilead wins FDA approval. Will it get to the people who need it?
The drug is groundbreaking, potentially eliminating the need for a long-sought-after HIV vaccine. In her own words: Anne ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
The Standard2d
Religious leaders, elders unite to end HIV by 2030
Despite decades of progress, stigma remains deeply entrenched in some communities and religious circles, where HIV is still associated with promiscuity and sin.
Daily Maverick on MSN2d
Minister Motsoaledi’s big HIV treatment jump: Is it true?
More than half a million people previously diagnosed with HIV have started on HIV treatment since the end of February, the ...